DDMAC Ruining Weekends? Warning Letters Usually Issued At Week's End
Executives worried about disciplinary action from FDA about pharmaceutical advertising may want to call in sick on Thursdays
You may also be interested in...
FDA's Division of Drug Marketing, Advertising and Communication appears to be shifting the way it writes citations to firms, increasing not just the number of letters it sends, but the number of problems it lists within each letter
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011